Evolutionary Genomics, Inc. Investing Cash Flow
Evolutionary Genomics, Inc. reported Investing Cash Flow of $0 for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2022-05-16
- Evolutionary Genomics, Inc. net cash provided by (used in) investing activities for the quarter ending 2022-03-31 was $0.00.
- Evolutionary Genomics, Inc. net cash provided by (used in) investing activities for the quarter ending 2021-03-31 was $0.00.
- Evolutionary Genomics, Inc. net cash provided by (used in) investing activities for the quarter ending 2020-03-31 was $0.00.
- Evolutionary Genomics, Inc. net cash provided by (used in) investing activities for the quarter ending 2017-09-30 was $749.60K, a 7.31% increase year-over-year.
- Evolutionary Genomics, Inc. net cash provided by (used in) investing activities for fiscal 2020 was $147.61K.
- Evolutionary Genomics, Inc. net cash provided by (used in) investing activities for fiscal 2016 was $156.13K, a 16.27% increase from fiscal 2015.
- Evolutionary Genomics, Inc. net cash provided by (used in) investing activities for fiscal 2015 was $134.28K.
- Evolutionary Genomics, Inc. net cash provided by (used in) investing activities for fiscal 2014 was -$1.47M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 35 month | Net Cash Provided by (Used in) Investing Activities 38 month |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | ||||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | ||||||
| 2020-12-31 | $147.61K 10-K · filed 2022-03-22 | ||||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-13 | ||||||
| 2017-09-30 | $749.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $997.76K derived: sum of 2 quarters · filed 2018-11-14 | -$502.18K 10-Q · filed 2018-11-14 | $958.22K derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $248.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$1.25M 10-Q · filed 2018-07-27 | $208.61K derived: sum of 3 quarters · filed 2018-07-27 | $907.17K derived: sum of 4 quarters · filed 2018-07-27 | |||
| 2017-03-31 | -$1.50M 10-Q · filed 2018-05-15 | -$1.50M 10-Q · filed 2017-05-11 | -$39.54K derived: sum of 2 quarters · filed 2018-05-15 | $659.02K derived: sum of 3 quarters · filed 2018-05-15 | $855.16K derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $2.16M derived: sum of 2 quarters · filed 2018-03-05 | $2.36M derived: sum of 3 quarters · filed 2018-03-05 | $156.13K 10-K · filed 2018-03-05 | |||
| 2016-09-30 | $698.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $894.71K derived: sum of 2 quarters · filed 2017-11-13 | -$1.30M 10-Q · filed 2017-11-13 | ||||
| 2016-06-30 | $196.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$2.00M 10-Q · filed 2017-08-03 | |||||
| 2016-03-31 | -$2.20M 10-Q · filed 2017-05-11 | ||||||
| 2015-12-31 | $134.28K 10-K · filed 2017-02-10 | ||||||
| 2014-12-31 | -$1.47M 10-K · filed 2016-02-19 | ||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-18 | $0.00 10-Q · filed 2011-11-18 | $0.00 10-Q · filed 2011-11-18 | ||||
| 2011-06-30 | $0.00 10-Q/A · filed 2011-08-17 | $0.00 10-Q/A · filed 2011-08-17 | |||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-18 | $0.00 10-Q · filed 2011-11-18 | |||||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-08-17 |